SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
DNA Brands, Inc. (DNAX) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 14/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DNAX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-15.15 |
$5.37K |
$-104K |
-1936% |
| 2016 |
$-11.32 |
$0.00 |
$-318K |
- |
| 2017 |
$-10.59 |
$0.00 |
$-315K |
- |
| 2018 |
$-15.65 |
$0.00 |
$-623K |
- |
| 2019 |
$-0.34 |
$18.07K |
$-181K |
-1001.8% |
| 2020 |
$-0.24 |
$249.01K |
$-1.25M |
-500% |
| 2021 |
$0.00 |
$459.33K |
$-304K |
-66.2% |
| 2022 |
$0.00 |
$0.00 |
$-375K |
- |
| 2023 |
$0.00 |
$0.00 |
$-703K |
- |
| 2024 |
$0.00 |
$0.00 |
$-523K |
- |